RecruitingNot ApplicableNCT07292961

Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma

Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach (BETY) in Children and Adults Diagnosed With Scleroderma: A Single-Blind Randomized Controlled Trial


Sponsor

Hacettepe University

Enrollment

48 participants

Start Date

Dec 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with scleroderma.


Eligibility

Min Age: 7 Years

Inclusion Criteria5

  • *For a child diagnosed with scleroderma*
  • Cases diagnosed with scleroderma,
  • Cases aged 7-18 years will be included.
  • Individuals diagnosed with scleroderma,
  • Individuals over the age of 18 will be included.

Exclusion Criteria10

  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Cases that are not willing to participate in the study will be excluded.
  • History of developmental delay
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study
  • *For adults diagnosed with scleroderma*
  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Individuals who are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCognitive Exercise Therapy Approach

The biopsychosocial model-based exercise approach (BETY) will be applied for 24 one-hour sessions, two days a week, for 3 months.

OTHERControl group

The control group will be followed up with a home exercise program, and notes will be taken.


Locations(1)

Hacettepe University

Ankara, Altındağ, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07292961


Related Trials